Information about the 2019 Novel Coronavirus
Epilepsy Impact Scale
Trial ID or NCT#
The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.
Questionnaire Development for a Comprehensive Scale to Measure the Impact of Epilepsy on Life.
- 1. Age 18 or more.
- 2. Patient has had at least 1 seizure in the past 365 days.
- 3. Patient can speak and understand English.
- 1. Patients suspected of having one of the imitators of epilepsy, for example, syncope, sleep disorder, psychogenic nonepileptic seizures, will be excluded, even if they also have epileptic seizures.
- 2. Patients unwilling to spend the time doing the questionnaire.
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToSPECTRUM
Go Back To The Trial